DNA X, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025

Published: 2026-04-15 15:28:53 ET SONM

Published on 04/15/2026 at 03:28 pm EDT

DNA X, Inc. reported earnings results for the full year ended December 31, 2025. For the full year, the company reported net loss was USD 20.66 million compared to USD 33.65 million a year ago. Basic loss per share from continuing operations was USD 11 compared to USD 11 a year ago.

Diluted loss per share from continuing operations was USD 11 compared to USD 11 a year ago. Basic loss per share was USD 28.58 compared to USD 128.37 a year ago. Diluted loss per share was USD 28.58 compared to USD 128.37 a year ago.